Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”

Author:

Li Kaiqing,Xia Xue,Fu Tong,Tong Ying

Funder

Heilongjiang University of Chinese Medicine

Scientific Research Fund for Young and Middle-Aged Scholars of Gansu University of Traditional Chinese Medicine

Publisher

Elsevier BV

Reference5 articles.

1. Apabetalone, a BET Protein Inhibitor, Inhibits Kidney Damage In Diabetes By Preventing Pyroptosis Via Modulating the P300/H3K27ac/PLK1 axis;Wang,2024

2. Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD);Taal;Nephrol. Dial. Transpl.,2023

3. Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes;Kaze;BMC Med.,2022

4. China Association of Traditional Chinese Medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine. Guidelines for the diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine. Journal of Beijing University of Traditional Chinese Medicine,2024,47(04):580-592.

5. Dulaglutide and kidney function-related outcomes in type 2 diabetes: a rewind post hoc analysis;Botros;Diabetes Care,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3